The Texas State Health Department has confirmed the findings of a Ayass BioScience, LLC laboratory that detected two North Texas cases of the omicron variant.
Ayass BioScience, LLC has detected the first two cases of the OMICRON variant in the DFW Metroplex using Next Generation Sequencing (NGS). This is a part of our [...]
COVID-19 is a "Perfect Storm for Heart Health" according to the World Heart Federation. 1. Individuals with COVID-19 and heart disease are at the highest risk of death and severe [...]
CARDIAC DISEASE AND GENETIC FACTORS Genes are what make you similar to your relatives. Problems (pathogenic mutations) in genes can cause your family members to be at risk for a [...]
Hereditary Cardiovascular Risk Assessment is the Most Effective Way of Identifying At-Risk Individuals or Confirming a Diagnosis of Existing Cardiac Conditions. It Opens the Door for More Precise and Individualized [...]
Genetic Testing of Fetal Cell Free DNA - No Risk to Pregnancy (in Contrast with Amniocentesis) Fetal Cell Free DNA is present in subtle amounts in the bloodstream from as [...]
Advanced Solution for Targeted Next Generation Sequencing (NGS) of Circulating Cell-Free Tumor DNA. ctDNA (Circulating Tumor DNA) consist of only a small fraction of cfDNA (Cell Free DNA). ctDNA mutations [...]
Quantity and Quality of DNA are Similar to Blood Methods! Ayass BioScience, LLC now accepts mouthwash as a collection method for genomic DNA for our Pharmacogenetic Testing. This method is [...]
SCREENING AND EARLY CANCER DETECTION • REAL TIME MONITORING OF CANCER THERAPY Dying cancer cells shed very small amount of DNA into blood. Gene-sequencing machines decode millions of short fragments [...]
The Mitochondrial genome is extremely small when compared to the nuclear genome, and mitochondrial DNA (mtDNA) mutations are complex and difficult to trace, but they play an important role in [...]
